The Dissemination Core (DisC) will increase the amount of high quality dissemination research conducted by UNC Lineberger investigators and accelerate the movement of new knowledge and evidence-based interventions (EBIs) into practice. Two broad categories of services will be offered: Investigator Services to facilitate the development and implementation of dissemination research; and Infrastructure Services to build dissemination capacity within our University and in North Carolina, with potential research collaborators and [isseminators of cancer-related EBIs. Investigator Services support research activities: technical assistance and consultation; and support in packaging/producing selected EBI program materials for dissemination. Four Infrastructure Services are as follows: collect, synthesize and communicate knowledge and recommended practices relevant to disseminating EBIs; develop/maintain partnerships for dissemination research; build dissemination capacity through technical assistance to key community partners; and identify high priority EBIs for dissemination. DisC's strong leadership team includes Drs. Barbara K. Rimer, DrPH, and Allan Steckler, DrPH, each with 20+ years of dissemination research experience; they have helped build this field of study from the ground level. Investigator Bryan J. Weiner, PhD has conducted original research on the adoption and implementation of innovations in clinical settings. Peer-reviewed members are projected to account for 100% of Investigator Services use. Use also includes services DisC will provide to organizations that collaborate with members on specific dissemination activities. Future plans are to increase the number of dissemination-related grants submitted and funded by Center investigators as a means of growing the field of dissemination research and increasing commitment to disseminating EBIs for cancer prevention and control.
We aim to play a central role in creating dissemination systems as a key strategy in controlling cancer. Cancer Center support is evidenced by its intent to allocate a minimum of one developmental project pet year to dissemination.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-31
Application #
7310764
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
31
Fiscal Year
2006
Total Cost
$130,096
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Wu, Bing; Zhang, Song; Guo, Zengli et al. (2018) RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs. Immunity 49:886-898.e5
Ding, Li; Bailey, Matthew H; Porta-Pardo, Eduard et al. (2018) Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell 173:305-320.e10

Showing the most recent 10 out of 1525 publications